Investigation of insulin resistance in patients with normocalcemic primary hyperparathyroidism

Endocrine

Volumn 42, Issue 2, 2012, Pages 419-422

  Cakir, Ilkay ^a   Unluhizarci, Kursad ^a   Tanriverdi, Fatih ^a   Elbuken, Gulsah ^a   Karaca, Zuleyha ^a   Kelestimur, Fahrettin ^a  

^a ERCIYES UNIVERSITY MEDICAL FACULTY   (Turkey)

Author keywords

Insulin resistance; Normocalcemic hyperparathyroidism

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; CREATININE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHATE; SERUM ALBUMIN; TRIACYLGLYCEROL;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; LIPID BLOOD LEVEL; MALE; ORAL GLUCOSE TOLERANCE TEST; PHOSPHATE BLOOD LEVEL; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL;

EID: 84867399105     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-012-9627-x     Document Type: Article

References (19)

1. S.J. Silverberg, J.P. Bilezikian, "Incipient" primary hyperparathyroidism. A "forme fruste" of an old disease. J. Clin. Endocrinol. Metab. 88, 5348-5352 (2003)
2. L.H. Duntas, N. Stathatos, Cinacalcet as alternative treatment for primary hyperparathyroidism: achievements and prospects. Endocrine 39, 199-204 (2011)
3. H. Lowe, D.J. McMahon, M.R. Rubin, J.P. Bilezikian, S.J. Silverberg, Normocalcemic primary hyperparathyroidism: further characterization of a new clinical phenotype. J. Clin. Endocrinol. Metab. 92, 3001-3005 (2007)
4. M. Procopio, G. Magro, F. Cesario et al., The oral glucose tolerance test reveals a high frequency of both impaired glucose tolerance and undiagnosed Type 2 diabetes mellitus in primary hyperparathyroidism. Diabetic Med. 19, 958-961 (2002)
5. E. Hagstrom, E. Lundgren, H. Lithell et al., Normalized dyslipidaemia after parathyroidectomy in mild primary hyperparathyroidism: population-based study over five years. Clin. Endocrinol. 56, 253-260 (2002)
6. W.H. Taylor, A.A. Khaleeli, Coincident diabetes mellitus and primary hyperparathyroidism. Diabetes Metab. Res. Rev. 17, 175-180 (2001)
7. S. Valdemarsson, P. Lindblom, A. Bergenfelz, Metabolic abnormalities related to cardiovascular risk in primary hyperparathyroidism: effects of surgical treatment. J. Int. Med. 244, 241-249 (1998)
8. S. Ayturk, A. Gursoy, N. Bascil Tutuncu, D.T. Ertugrul, N. Guvener Demirag, Changes in insulin sensitivity and glucose and bone metabolism over time in patients with asymptomatic primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 91, 4260-4263 (2006)
9. E. Hagstrom, E. Lundgren, J. Rastad, P. Hellman, Metabolic abnormalities in patients with normocalcemic hyperparathyroidism detected at a population-based screening. Eur. J. Endocrinol. 155, 33-39 (2006)
10. E. Bonora, G. Targher, M. Alberiche et al., Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity. Diabetes Care 23, 57-63 (2000)
11. American Diabetes Association: clinical practice recommendations 1997. Diabetes Care 20(Suppl 1), S1-S70 (1997)
12. N.B. Dimkovic, A.A. Wallele, D.G. Oreopoulos, Renal stone disease, elevated iPTH level and normocalcemia. Int. Urol. Nephrol. 34, 135-141 (2002)
13. R.E. Burney, K.R. Jones, B. Christy, N.W. Thompson, Health status improvement after surgical correction of primary hyperparathyroidism in patients with high and low preoperative calcium levels. Surgery 125, 608-614 (1999)
14. E. Hagstrom, P. Hellman, E. Lundgren, L. Lind, J. Arnlov, Serum calcium is independently associated with insulin sensitivity measured with euglycaemic-hyperinsulinaemic clamp in a community- based cohort. Diabetologia 50, 317-324 (2007)
15. A.A. Khaleeli, J.N. Johnson, W.H. Taylor, Prevalence of glucose intolerance in primary hyperthyroidism and the benefit of parathyroidectomy. Diabetes Metab. Res. Rev. 23, 43-48 (2007)
16. G. Sun, S. Vasdev, G.R. Martin, V. Gadag, H. Zhang, Altered calcium homeostasis is correlated with abnormalities of fasting serum glucose, insulin resistance and beta cell function in the Newfoundland population. Diabetes 54, 3336-3339 (2005)
17. T. Yamaguchi, I. Kanazawa, S. Takaoka, T. Sugimoto, Serum calcium is positively correlated with fasting plasma glucose and insulin resistance, independent of parathyroid hormone, in male patients with type 2 diabetes mellitus. Metab. Clin. Exp. 60, 1334-1339 (2011)
18. F. Tassone, M. Procopio, L. Gianotti, G. Visconti, A. Pia, M. Terzolo, G. Borretta, Insulin resistance is not coupled with defective insulin secretion in primary hyperparathyroidism. Diabet Med. 26, 968-973 (2009)
19. J.P. Bilezikian, S.J. Silverberg, Normocalcemic primary hyperparathyroidism. Arq. Bras. Endocrinol. Metab. 54, 106-109 (2010)